Anatomic Pathology Market: Business Growth, Development Factors, Application and Future Prospects by 2021
Anatomic Pathology Market by Product & Service (Instruments (Tissue Processing Systems, Microtome), Consumables (Reagent & Antibodies), Histopathology, Cytopathology), Application (Disease Diagnosis, Drug Discovery & Development) - Forecasts to 2021
(EMAILWIRE.COM, November 04, 2018 ) According to the new market research report “Anatomic Pathology Market by Product & Service (Instruments (Tissue Processing Systems, Microtome), Consumables (Reagent & Antibodies), Histopathology, Cytopathology), Application (Disease Diagnosis, Drug Discovery & Development) - Forecasts to 2021", published by MarketsandMarkets™, This report provides a detailed overview of the major drivers, restraints, challenges, opportunities, trends and strategies impacting the Anatomic Pathology Market, along with revenue estimates & forecasts and market share analysis.
Don’t miss out on business opportunities in “Anatomic Pathology Market”. Speak to our analyst and gain crucial industry insights that will help your business grow: http://bit.ly/2P4rMxV
The global anatomic pathology market is expected to reach USD 21.9 Billion by 2021 from USD 16.2 Billion in 2016, at a CAGR of 6.1% from 2016 to 2021. The increasing prevalence of chronic diseases, growing aging population, and increasing healthcare expenditure are the major factors driving the growth of this market.
On the basis of product and service, the anatomic pathology market is segmented into instruments, consumables, and services. The instruments segment has been subsegmented into tissue processing systems, slides staining systems, microtomes, and other instruments. Similarly, the consumables segment has been subsegmented into reagents & antibodies, probes, kits, and other consumables. Likewise, the services segment has been subsegmented into cytopathology, histopathology, and other services. In 2016, the services segment accounted for the largest share of the market. This growth can be attributed to the increasing prevalence of chronic diseases and the subsequent growth in the number of anatomic pathology tests.
In the instrument subsegment, the tissue processing systems segment accounted for the largest share of the anatomic pathology market in 2016 due to the increasing automation in the instruments that improve the quality of diagnosis process. Similarly, in the consumables subsegment, the reagents & antibodies segment accounted for the largest share of the market, in 2016. This is due to increasing number of diagnostics tests that fuel the utilization of reagents & antibodies. Likewise, in the services subsegment, the histopathology segment accounted for the largest market share in 2016. This is mainly due to their use in the diagnosis of a wide range of chronic diseases, such as cancer, and bacterial and viral diseases.
On the basis of application, the anatomic pathology market is segmented into disease diagnosis, drug discovery & development, and other applications. The disease diagnosis segment accounted for the largest market share in 2016. The rapid growth in the aging population and increasing incidence of cancer and other chronic diseases is a key market driver in this segment. The drug discovery & development segment accounted for the second largest share in 2016. Increasing R&D expenditure is driving the adoption of anatomic pathology services in pharmaceutical and biopharmaceutical companies for drug discovery & development applications.
Browse and in-depth TOC on “Anatomic Pathology Market”
80 - Tables
32 - Figures
129 - Pages
View more detailed TOC @ https://www.marketsandmarkets.com/Market-Reports/anatomic-pathology-market-137323145.html
On the basis of region, the global anatomic pathology market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). Asia is expected to grow at the highest CAGR during the forecast period. The presence of emerging economies like China, India, and Japan; the large population and rising prevalence of chronic diseases in these countries; improving standards of living; growing demand for quality medical care; increasing healthcare spending and government initiatives; rising awareness about the use of anatomic pathology tests among physicians; and growth in the demand for diagnostics are some major factors driving the high growth of this regional segment.
Some of the major players operating in the anatomic pathology market are F. Hoffmann-La Roche AG (Switzerland), Thermo Fisher Scientific (U.S.), Danaher Corporation (U.S.), Agilent Technologies (U.S.), Sakura Finetechnical Co., Ltd. (Japan), Quest Diagnostics Incorporated (U.S.), Laboratory Corporation of America Holdings (U.S.), and NeoGenomics Laboratories, Inc. (U.S.).
Request for Free Sample Report @ http://bit.ly/2yPeYBg
Browse Adjacent Markets @ Medical Devices Market Research Reports & Consulting
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Contact:
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: 1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com
Don’t miss out on business opportunities in “Anatomic Pathology Market”. Speak to our analyst and gain crucial industry insights that will help your business grow: http://bit.ly/2P4rMxV
The global anatomic pathology market is expected to reach USD 21.9 Billion by 2021 from USD 16.2 Billion in 2016, at a CAGR of 6.1% from 2016 to 2021. The increasing prevalence of chronic diseases, growing aging population, and increasing healthcare expenditure are the major factors driving the growth of this market.
On the basis of product and service, the anatomic pathology market is segmented into instruments, consumables, and services. The instruments segment has been subsegmented into tissue processing systems, slides staining systems, microtomes, and other instruments. Similarly, the consumables segment has been subsegmented into reagents & antibodies, probes, kits, and other consumables. Likewise, the services segment has been subsegmented into cytopathology, histopathology, and other services. In 2016, the services segment accounted for the largest share of the market. This growth can be attributed to the increasing prevalence of chronic diseases and the subsequent growth in the number of anatomic pathology tests.
In the instrument subsegment, the tissue processing systems segment accounted for the largest share of the anatomic pathology market in 2016 due to the increasing automation in the instruments that improve the quality of diagnosis process. Similarly, in the consumables subsegment, the reagents & antibodies segment accounted for the largest share of the market, in 2016. This is due to increasing number of diagnostics tests that fuel the utilization of reagents & antibodies. Likewise, in the services subsegment, the histopathology segment accounted for the largest market share in 2016. This is mainly due to their use in the diagnosis of a wide range of chronic diseases, such as cancer, and bacterial and viral diseases.
On the basis of application, the anatomic pathology market is segmented into disease diagnosis, drug discovery & development, and other applications. The disease diagnosis segment accounted for the largest market share in 2016. The rapid growth in the aging population and increasing incidence of cancer and other chronic diseases is a key market driver in this segment. The drug discovery & development segment accounted for the second largest share in 2016. Increasing R&D expenditure is driving the adoption of anatomic pathology services in pharmaceutical and biopharmaceutical companies for drug discovery & development applications.
Browse and in-depth TOC on “Anatomic Pathology Market”
80 - Tables
32 - Figures
129 - Pages
View more detailed TOC @ https://www.marketsandmarkets.com/Market-Reports/anatomic-pathology-market-137323145.html
On the basis of region, the global anatomic pathology market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). Asia is expected to grow at the highest CAGR during the forecast period. The presence of emerging economies like China, India, and Japan; the large population and rising prevalence of chronic diseases in these countries; improving standards of living; growing demand for quality medical care; increasing healthcare spending and government initiatives; rising awareness about the use of anatomic pathology tests among physicians; and growth in the demand for diagnostics are some major factors driving the high growth of this regional segment.
Some of the major players operating in the anatomic pathology market are F. Hoffmann-La Roche AG (Switzerland), Thermo Fisher Scientific (U.S.), Danaher Corporation (U.S.), Agilent Technologies (U.S.), Sakura Finetechnical Co., Ltd. (Japan), Quest Diagnostics Incorporated (U.S.), Laboratory Corporation of America Holdings (U.S.), and NeoGenomics Laboratories, Inc. (U.S.).
Request for Free Sample Report @ http://bit.ly/2yPeYBg
Browse Adjacent Markets @ Medical Devices Market Research Reports & Consulting
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Contact:
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: 1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com
Contact Information:
MarketsandMarkets™
Mr. Shelly Singh
Tel: 1-888-600-6441
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
MarketsandMarkets™
Mr. Shelly Singh
Tel: 1-888-600-6441
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results